[EN] AGROCHEMICAL COMPOSITION COMPRISING 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS AND USE THEREOF [FR] COMPOSITION AGROCHIMIQUE COMPRENANT DES COMPOSÉS PHÉNYLAMIDINE 3-SUBSTITUÉS ET LEUR UTILISATION
[EN] INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL<br/>[FR] INHIBITEURS DU CANAL POTASSIQUE MÉDULLAIRE EXTERNE RÉNAL
申请人:MERCK SHARP & DOHME
公开号:WO2010129379A1
公开(公告)日:2010-11-11
This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure.
[EN] 3-SUBSTITUTED PHENYLAMIDINE COMPOUNDS, PREPARATION AND USE THEREOF<br/>[FR] COMPOSÉS DE PHÉNYLAMIDINE 3-SUBSTITUÉS, LEUR PRÉPARATION ET LEUR UTILISATION
申请人:PI INDUSTRIES LTD
公开号:WO2020148617A1
公开(公告)日:2020-07-23
The present invention disclosed 3-substituted phenylamidine compounds of general formula (I), wherein R1, R2, R3, R4, R4a, R4b, A and E have the same meanings as defined in description. The present invention further discloses methods for their preparation and use of the compounds of general formula (I) as a crop protection agent.
GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZONITRILE DERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE
申请人:Himmelsbach Frank
公开号:US20100069310A1
公开(公告)日:2010-03-18
Glucopyranosyl-substituted benzyl-benzonitrile derivatives of general formula (I) as defined according to claim
1
, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
申请人:Merck Sharp & Dohme Corp.
公开号:US20140142115A1
公开(公告)日:2014-05-22
This invention relates to compounds having structural Formula I:
and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure.